Table 6 Linear mixed effects models of changes in the levels of UA and UA/Cr ratio between severe and moderate symptoms and three time points by gender
From: Association of serum uric acid levels with COVID-19 severity
Fixed Effects | UA | UA/Cr ratio | ||||||
|---|---|---|---|---|---|---|---|---|
Male | Female | Male | Female | |||||
Effect Size | 95% CI | Effect Size | 95% CI | Effect Size | 95% CI | Effect Size | 95% CI | |
Moderate | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Severe | − 0.17 | (− 0.29, − 0.05) | 0.07 | (− 0.11, 0.24) | − 0.19 | (− 0.35, − 0.04) | 0.02 | (− 0.15, 0.19) |
Admission | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Discharge | − 0.05 | (− 0.12, 0.01) | − 0.11 | (− 0.18, − 0.04) | −0.06 | (− 0.14, 0.01) | − 0.18 | (− 0.25, − 0.12) |
Follow-up | 0.04 | (− 0.04, 0.13) | 0.04 | (− 0.03, 0.11) | 0.05 | (− 0.04, 0.14) | −0.03 | (− 0.10, 0.04) |